Aranthan Jones II, Chief Corporate Affairs Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 14,626 shares at $10.62 ($155K) on 2020-07-27, disclosed to the SEC on 2020-07-29.
Open-market sale of $155k VNDA by Chief Corporate Affairs Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.62 | 7,313 | $78K | 50.0% |
| 2 | $10.62 | 7,313 | $78K | 50.0% |
| Total | $10.62 avg | 14,626 | $155K | 100% |
| Filing → |
| VNDA | SELL | 2021-03-16 | $319K | — | Filing → |
| VNDA | SELL | 2021-03-03 | $139K | — | Filing → |
| VNDA | SELL | 2021-02-26 | $920K | — | Filing → |